A randomised, double-blind study was conducted to investigate the postoperative effects of subarachnoid morphine, with or without adrenaline, after major gynaecological surgery. Seventy-five women having spinal anaesthesia combined with either sedation or general anaesthesia were randomised to receive subarachnoid morphine 0.25 mg with (group MA) or without (group M) adrenaline 200 p,g; or normal saline (group C). Groups M (n =22) and MA (n =25) differed significantly from control (n=23) with respect to the quality and duration of postoperative analgesia (P<0.0002) and to a higher incidence of pruritus (P< 0.02). Groups were similar with respect to the incidence of other postoperative side-effects and respiratory data, although the latter showed a trend to less hypoxaemia in the control group. There was no significant difference in any outcome between groups MA and M It was concluded that, under the study conditions in a post-gynaecological surgery population, the addition of adrenaline to subarachnoid morphine was of no benefit.
which had hospital Research and Ethics Committee approval.
Anaesthetic technique consisted of premedication with oral temazepam 20 mg; epidural catheterisation at Ll-2; spinal anaesthesia and according to patient preference, intraoperative sedation (intravenous midazolam) or general anaesthesia (IV propofol and nitrous oxide in oxygen, breathing spontaneously via a laryngeal mask). Neither epidural drugs nor systemic opioids were administered perioperatively. Subarachnoid block was performed in the lateral position at L2-3 or L3-4 interspace using a 24 gauge Sprotte needle for patients less than 60 and a 25 gauge Quincke-point needle for those over 60 years of age. In addition to 3-4 ml of subarachnoid hyperbaric bupivacaine 0.5070 (as appropriate for the surgery), patients were randomised according to a computergenerated random number list to one of three groups, to receive a freshly prepared study solution (0.2 ml) containing morphine 0.25 mg (group M), morphine 0.25 mg plus adrenaline 200 mcg (group MA), or normal saline (group C).
Patient characteristics and demographic data included age, weight and baseline pulse oximetric arterial haemoglobin oxygen saturation (SpOz) after premedication, type of operation and duration of surgery.
Postoperatively, analgesia was assessed by serial pain scores at rest, at 2, 4, 6, 8, 12, 16, 20 and 24 hours, unless a request for postoperative pain relief was made, after which scores were no longer recorded and epidural opioid analgesia with continuous fentanyl infusion was instituted. The duration of complete analgesia was defined as the time to the last recorded pain score of zero. Duration of effective analgesia was defined as the time to the first request for postoperative pain relief. In those patients still not requesting analgesia at 24 hours postoperatively, duration was deemed to be 1440 minutes. At 24 hours patients were asked to quantify their satisfaction with their pain relief on an unmarked 10 cm scale labelled "totally unsatisfactory" at one end and "couldn't have been happier" at the other. They were also asked if they would choose the same technique again.
Postoperative nausea and vomiting was assessed using a four-point scale (0 = nil; 1 = nausea only; 2=vomiting; 3 = persistent vomiting despite treatment (IM prochlorperazine 12.5 mg 6 hrly pm by two doses, then IM droperidol l.25 mg if required). Pruritus was recorded on a three-point scale (0 = nil; 1 = mild; 2 = severe, treatment requested (IM naxolone 0.2 mg 2 hrly)). Respiratory monitoring consisted of routine hourly nursing observation of respiratory rate and conscious state, plus Sp02 hourly on air in all participants until 24 hours postoperatively. Patients in whom Sp02 fell below 93070 on air were given supplemental oxygen until the next assessment. At discharge evidence for postdural puncture headache or inability to micturate (after postoperative removal of the urinary catheter) was sought.
Data were described using mean and standard deviation or median and interquartile range as appropriate. The F test was used to test for differences between groups for patient data, and Kruskall-Wallis one-way analysis of variance for ordinal data, pain scores and duration of pain relief. Differences in time to first request for analgesia were tested with generalised Wilcoxon and Savage log-rank tests and side-effects with chi-squared and Fisher's exact test; or with F and t tests for continuous data. A P value of < 0.05 was considered statistically significant.
RESULTS
Four women were withdrawn from the study because of failure to achieve adequate spinal anaesthesia for surgery, and one due to failure to follow study protocol. This left 70 analysed data sets (group M, n=22; group MA, n=25; group C, n=23).
Patient Characteristics
There was no significant difference between groups with respect to patient age, weight, preoperative Sp02; or the duration of surgery and type of procedure (Table 1) . The median pain score in groups M and MA was zero throughout the study period. The duration of complete analgesia and time to first postoperative pain relief differed significantly from control but not between groups M and MA ( Table 2 ). Data showing the percentage of patients in each group still not requiring postoperative pain relief at each assessment interval is illustrated in Figure l . Patient satisfaction with their postoperative analgesia was similar for all groups (Table 3) .
Side-Effects
Side-effects are detailed in Table 4 . Significantly fewer women in the control group experienced pruritus, but its incidence in groups M and MA was similar. Nausea and vomiting were common and similar in all groups, about one in seven having persistent vomiting despite treatment. 
The number of women having respiratory rates less than ten, Sp02 less than 93070 and the difference between preoperative Sp02 and lowest recorded postoperative Sp02 are shown in Table 5 . There was a nonsignificant trend for fewer women in the control group to experience desaturation below 93070 (P=0.06) and to have a reduced fall in Sp02 (P=0.08).
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DISCUSSION

Adrenaline and intraspinal opioids
The addition of adrenaline to epidurally-administered lipophilic opioid enhances postoperative analgesia. Adrenaline added to epidural morphine increases cutaneous hypalgesia, ' Respiratory data (number with respiratory rate less than ten and arterial haemoglobin oxygen saturation [Sp 021less than 93%; the difference between preoperative and lowest postoperative S p 02) studies of postoperative analgesia have found no benefit. 22,24,25 The duration of postoperative analgesia after epidural morphine appears to be related to the CSF concentration of morphine, and adrenaline does not significantly increase the CSF morphine concentration after epidural administration,26 nor does it affect the systemic absorption of intrathecal morphi ne. 27 Its effect on CSF pharmacokinetics after intrathecal administration is unknown. In animals, the addition of an a-adrenergic agonist to opioid further suppresses the noxiously evoked neuronal activity of wide-dynamic range neurons, and increases analgesia in a multiplicative fashion. ' 6,17 In formulating this study, it was postulated that adrenaline added to subarachnoid morphine might enhance early postoperative analgesia and/or the duration of effective analgesia, as has recently been described when adrenaline was combined with subarachnoid fentanyl. 17 However, under the study conditions, neither the quality of early postoperative pain relief not its duration were affected by the addition of adrenaline. Possible explanations for this lack of enhancement include differences in the intensity of surgical stimulus, the patient populations, opioid pharmacokinetics and the possibility that termination of the study at 24 hours, when almost a third of patients in the study groups had still not required pain relief, precluded detection of a difference between groups.
Analgesia and acceptability
Initial clinical studies of postoperative analgesia with subarachnoid morphine demonstrated the effectiveness of 1 to 20 mg doses, but the technique failed to achieve popularity because of the high incidence of side-effects and, more sinisterly, delayed respiratory depression. Nevertheless, the lumbar administration of subarachnoid local anaesthetic and morphine provides the potential for high quality surgical anaesthesia and prolonged postoperative analgesia via a technically simple, cheap, single-shot injection. 28 Evaluations of doses up to 0.3 mg have been encouraging, and delayed respiratory depression has not been reported. The quality of analgesia obtained after subarachnoid morphine 0.25 mg in this study was usually very good and often of many hours duration, although not as lengthy as after caesarean section. 5-7,10 The majority of patients had analgesia persisting at least 12 hours, with 30070 remaining in no need of pain relief 24 hours after surgery. These results differ markedly, however, from those of a Japanese study after abdominal hysterectomy, where smaller morphine doses (0.04 to 0.1 mg) resulted in analgesia beyond 24 hours in over 60% of cases. 12 It is notable, however, that some women receiving subarachnoid morphine appeared to obtain little, or very short-lived, pain relief-22% required alternative postoperative analgesia within four hours of surgery. Poor reliability has been reported after similar doses for major orthopaedic surgery, where three of ten patients required supplementation within five hours 9 and after caesarean section, where 30% requested it within eight hours. 15 Possible explanations for marked inter-individual differences in duration of effect are the known variability in CSF morphine kinetics after intrathecal administration (threefold variation in maximum CSF concentration and halflife),2 and differences (including age-related) in pharmacodynamic response. Concentrations of CSF morphine after epidural administration are higher in elderly patients,29 and this may account for the importance of age in determining response to epidural morphine. 30, 31 In this study, Pearson correlation coefficients showed positive correlations between duration of effective analgesia and both age and vaginal surgery. As the study was not, however, designed to test whether age, or operation type, affected the duration of analgesia, a controlled study is needed to determine whether age is also a factor determining the effectiveness of subarachnoid morphine.
Side-Effects
A high incidence of minor side-effects is a significant source of patient dissatisfaction with subarachnoid morphine. 10 As previously described, pruritus occurred frequently5,7,9 and was of sufficient severity to require treatment in 21 % of patients. A similar incidence has been reported with 0.2 mg for caesarean section. 5 Sideeffects may be partly dose-related and Yamaguchi and colleagues 12 reported pruritus in only 3% of patients, although direct questioning was not used. The addition of adrenaline to epidural morphine may increase the incidence of pruritus,19,21 yet 200 J1.g added to subarachnoid fentanyl (which when used intraspinally causes less pruritus than morphine) significantly reduced it. 17 The results of this study fail to support either a beneficial or adverse effect on intraspinal opioid-induced pruritus. Adrenaline is also said to increase the incidence of nausea after epidural morphine 19 and subarachnoid fentanyl, 18 although others report no change. 22, 23 In this study, in which no prophylactic antiemetics were given, the incidence of nausea and vomiting was very high and similar in all groups. This reflects the high emetogenic potential of gynaecological surgery, where symptoms occur in 60-100% of women irrespective of analgesic technique. The results again contrast strikingly with those of Yamaguchi et ai, who reported vomiting in only 30% of the placebo group and in significantly fewer women receiving 0.03 to 0.08 mg of subarachnoid morphine. 12 Urinary retention is a recognised complication of intraspinal opioid (11 % in a large series given subarachnoid morphine for post caesarean section analgesia),5 but was not a concern in this patient population, recatheterisation being required in only four women (6%), including two from the placebo group. Post dural puncture headache occurred in two women (age 32 and 67 years, on day one and four respectively) but in both cases proved transient, settling with conservative management within twenty-four hours. Unsubstantiated claims suggest epidural morphine is an effective prophylactic against post dural puncture headache, but that intrathecal morphine appears to have no significant effect. 32 Delayed respiratory depression is the most feared complication of intraspinal morphine. However, 0.1 to 0.25 mg doses have no effect on respiratory rate, minute ventilation and C02 response curves in women after caesarean section. 6,7 Furthermore, respiratory depression, based on pulse oximetry, arterial carbon dioxide tension and C02 ventilatory response curves, is less than that from parenteral morphine. 6, 7, 9, 13 Clinical reports of severe respiratory depression are usually after doses of 1 mg or more,9,33 although recently a combination of only 0.2 mg with subarachnoid fentanyl produced early onset severe respiratory depression 34 and doses of only 0.15 mg were associated with significant depression after cholecystectomy. 12 In this study, data was collected intermittently and thus its value is limited. Although no patient had clinically significant respiratory depression requiring naloxone, respiratory rates of less than ten were only noted in patients who had received subarachnoid morphine, and episodes of desaturation were also more common, though not significantly. Unfortunately, respiratory rate is known to be a poor predictor of opioid-induced respiratory depression 35,36 and hypoventilation, periodic breathing and hypoxaemia are very common after both midazolam sedation, general anaesthesia and surgery. In a large study using continuous pulse oximetry after Anaesthesia and Intensive Care, Vo!. 21, No, I, February, 1993 0.2 mg subarachnoid morphine for caesarean section, patients who desaturated profoundly were obese, obstructed during sleep and most showed no response to naloxone. 10 The contribution of subarachnoid morphine to the postoperative respiratory depression detected in this study is thus not clear, but further detailed investigation of its respiratory effects in nonobstetric and high-risk patients would be of interest.
CONCLUSION
Despite the appeal of a single-shot approach to anaesthesia and postoperative analgesia, 0.25 mg of subarachnoid morphine, with or without adrenaline, did not reliably produce prolonged postoperative analgesia after major gynaecological surgery and the frequency of side-effects was high. Nevertheless, the quality of pain relief was very good and patient satisfaction similar to that of a control group receiving epidural fentanyl analgesia. It is possible a higher morphine dose (0.4 mg or more) may have improved the reliability and duration of effecC·'4.J7 but sideeffects, especially respiratory depression, remain a potential concern. Although it may prove impossible to find a standard dose of subarachnoid morphine, this technique appears to have merit, and large doseresponse studies determining efficacy and side-effects for different patient ages and specific operations would be of considerable clinical value. Adrenaline injected at the time of establishing spinal anaesthesia had no influence on either postoperative analgesia from subarachnoid morphine or on opioid-induced sideeffects.
